Powerful anti-vaccine advocates and people selling potentially harmful goods are profiting from the push to write ...
China's pharmaceutical sector, once driven largely by generic drug production, is now witnessing a steady rise in innovative ...
Zacks Investment Research on MSN
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
() -Several pharmaceutical companies have said they will sell drugs direct to patients in the U. and offered discounts ...
The pharmaceutical sector dominates end-user demand, accounting for 44.7% of the Japanese healthcare and laboratory label ...
Trump plans 100% tariff on branded drugs imported to U.S. BioNJ, HINJ warn of risks to patients, jobs & innovation Major pharma firms investing billions in U.S. production sites Industry groups urge ...
In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...
Investors in ETFs such as SPDR S&P Pharmaceuticals ETF (NYSE: XPH), First Trust NASDAQ Pharmaceuticals ETF (NASDAQ: FTXH), iShares U.S. Pharmaceuticals ETF (NYSE: IHE), and VanEck Pharmaceutical ETF ...
AstraZeneca AZN-0.71%decrease; red down pointing triangle said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for ...
Global drugmakers including Merck & Co., Eli Lilly & Co. and AstraZeneca Plc are pausing or canceling investments in the UK while throwing barbs at the lack of competitiveness of its business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback